Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.75
Price to sales ratio
1.32

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3046
TENX
Tenax Therapeutics, Inc. - Common Stock
15.98 USD-8.95%-1.36%+37.17%+111.66%423.87 M USD
3053
AGMB
AgomAb Therapeutics NV - ADRs representing one
12.31 USD-5.89%-9.68%+24.47%-16.26%420.60 M USD
3075
CMPX
Compass Therapeutics, Inc. - Common Stock
2.26 USD-3.00%-1.74%+10.24%-23.91%407.00 M USD
3081
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.72 USD-4.86%-6.77%+32.38%+21.97%406.20 M USD

Frequently asked questions about Puma Biotechnology Inc - Common Stock

What is the Puma Biotechnology Inc - Common Stock stock price today?

The current price of Puma Biotechnology Inc - Common Stock (PBYI) is 8.08. Over the past 24 hours, the stock has changed by +1.00%. Follow the PBYI chart for real-time price dynamics.

What is the stock ticker of Puma Biotechnology Inc - Common Stock?

Puma Biotechnology Inc - Common Stock trades under the ticker PBYI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Puma Biotechnology Inc - Common Stock stock going up?

PBYI has changed by -1.82% over the last week, +9.49% over the last month, and +127.61% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Puma Biotechnology Inc - Common Stock net income for the last quarter?

Puma Biotechnology Inc - Common Stock reported net income of -3.75 M for the last quarter. The previous quarter showed 13.44 M, which means net income changed by -127.93%.

How many employees does Puma Biotechnology Inc - Common Stock have?

As of the latest available data, Puma Biotechnology Inc - Common Stock has 179 employees. Workforce size can provide additional context about the company's scale and operations.

What is Puma Biotechnology Inc - Common Stock EBITDA?

Puma Biotechnology Inc - Common Stock EBITDA is -1.33 M, and its EBITDA margin is -2.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Puma Biotechnology Inc - Common Stock stock?

You can buy Puma Biotechnology Inc - Common Stock (PBYI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Puma Biotechnology Inc - Common Stock stock?

Investing in Puma Biotechnology Inc - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PBYI chart and related analysis on metatrader.com as part of your research.

Puma Biotechnology Inc - Common Stock

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

News